Abstract
Objective
Mobile health (mHealth) technologies are emerging to support the delivery of pulmonary rehabilitation (PR). This study aimed to explore the ease of use, satisfaction and acceptability of an Australian mobile pulmonary rehabilitation app (m-PR™) in people with chronic obstructive pulmonary disease (COPD).
Methods
In this mixed methods observational study, participants with COPD were recruited following PR assessment. Participants were educated on m-PR™ which contained symptom monitoring, individualised exercise training with exercise videos, education videos, goal setting, health notifications and medication action plan. Participants used m-PR™ for 4–8 weeks. At baseline, participants were surveyed to assess level of technology engagement. At follow-up, participants completed the system usability survey (SUS), a satisfaction survey and a semi-structured interview.
Results
Fifteen participants (mean age 70 [SD 10] years, 53% female) completed the study. Technology usage was high with 73% (n = 11) self-rating their technology competence as good or very good. The SUS score of 71 (SD 16) demonstrated above average perceived usability of m-PR™. The satisfaction survey indicated that 67% (n = 10) enjoyed m-PR™ and 33% (n = 5) were neutral. Most participants found the different m-PR™ components somewhat easy or very easy to use (range 69–100%) and somewhat helpful or very helpful (range 76–100%). Interview responses revealed that m-PR™ elicited divergent feelings among participants, who reported both positive and negative feelings towards the app's features, the effort required to use it and data security.
Conclusion
The majority of participants found m-PR™ enjoyable, easy to use and helpful in managing their COPD. Further research is warranted to understand the effectiveness of mHealth to deliver PR.
Keywords
Introduction
Pulmonary rehabilitation (PR) is an effective non-pharmacological intervention for people with chronic obstructive pulmonary disease (COPD). 1 Barriers to access, uptake, attendance and completion of traditional outpatient PR programs are well documented. 2 Home-based programs are a safe and feasible alternative to outpatient PR programs to improve availability and access 3 and are comparable to outpatient PR in reducing dyspnoea and improving exercise capacity and health-related quality of life (HRQoL).4,5
With increasing use of mobile health (mHealth) technology, providing a comprehensive digitalised PR program is now possible and has the potential to expand access to PR. People with COPD report a substantial engagement with technology and willingness to use technology-assisted PR 6 and short-term PR programs using mHealth technology have now been developed and tested in multiple countries.7–13 Of the studies to date, three have included some element of user experience and satisfaction testing of the mHealth PR programs with general acceptability being reported.8,9,12 The mobile PR app (m-PR™) is the first Australian specific mHealth PR program which allows people with COPD to complete a home-based PR program supported by mHealth technology. Guidelines for reporting of mHealth interventions outline the importance of user experience testing and user feedback during the design process before investigating effectiveness, 14 therefore this formative study was undertaken as part of the m-PR™ development process. The aim of this study was to determine the ease of use, satisfaction and acceptability of m-PR™ in people with COPD.
Methods
Study design and participants
This mixed methods observational study was conducted between November 2020 and November 2021. A convenience sample of participants with COPD was recruited following an initial PR assessment (either in-person or via teleconsultation) at three sites in Sydney, Australia. Any patient with COPD aged over 40 years was invited to take part in the study if they were willing and had access and ability to use a smartphone and had a data plan. People were excluded if they had: supplemental oxygen requirements during the exercise assessments or training procedures; limited skills in the use of mobile technology; or limited English language.
Intervention
The m-PR™ platform was co-created by a team of technology and health experts together with consumers. Software engineers from the Australian eHealth Research Centre (Commonwealth Scientific and Industrial Research Organisation [CSIRO]) built the platform based on the material design framework (https://m3.material.io/). The software is available on the Apple App Store (iOS) and the Google Play Store. The health experts consisted of academics and multi-disciplinary clinicians who are considered specialists in the field of PR. The m-PR™ platform contains both a patient app (being evaluated during this study) and a clinician web-based portal. The patient-facing m-PR™ app consists of daily monitoring of COPD symptoms, a tailored individualised exercise program with demonstration videos, education videos, medical management through a virtual “Lung Foundation Australia” action plan 15 and goal setting for behaviours such as increasing daily physical activity levels and reducing smoking. Patient-reported outcome measures being the COPD Assessment Test (CAT) and the Modified Medical Research Council Dyspnoea Scale (mMRC) were also integrated within the m-PR™ app with users prompted to complete on a weekly or daily basis respectively. Health coaching was provided through regular in-app notifications and through weekly contact with the physiotherapist. The m-PR™ clinician portal allows the clinician to upload individualised exercise prescription and educational videos, track each participant's progress and also provide consistent data capture across the participating PR programs. Further details of the m-PR™ platform components are available. 16 Participants were provided with a 30-min education session about how to use m-PR™, and were asked to engage daily with the m-PR™ app for 4 to 8 weeks whilst completing their standard 8 week PR program. The 4–8 weeks duration was given as an option as within 4 weeks of using the m-PR™ app all the possible functionalities within the app would have been used by the participant. The standard PR program was completed either in the centre with twice weekly exercise sessions with one face-to-face education session or independently at home with twice weekly exercise sessions, once-a-week telephone support and education provided through the m-PR™ app. Weekly contact with the physiotherapist was provided either in the centre or via telephone to address any questions the participant had about using the m-PR™ app or general questions about their PR program. Participants were also able to contact the physiotherapist by telephone at any point if they had any questions about the m-PR™ app or their general PR program.
Data collection
Demographic and clinical characteristics
Baseline demographic information collected included age, sex, smoking history, and comorbidities. At baseline, all participants either completed spirometry or had recent spirometry results (within the last 6 months if clinically stable) recorded. Baseline technology engagement was assessed with a custom-designed survey (in appendix), wherein participants indicated which devices they access, the frequency of use, use of their devices to access other types of digital information (e.g., shopping, banking, health information) and their self-rated mobile technology skill competency.
Outcome measures
Participant satisfaction survey
A custom-designed satisfaction survey (in appendix) was used to explore participants’ experience with the m-PR™ app. The survey contained four primary questions with responses on a 5-point Likert scale and one open-ended question. The questions were designed to determine the degree of enjoyment of using the m-PR™ app, the perceived ease and helpfulness of utilising different components of the m-PR™ app, and the helpfulness of the m-PR™ program at improving motivation to exercise and at monitoring and managing COPD symptoms. The closed-ended questions required participants to tick a box in response to each question. The open-ended question enabled participants to express in writing which parts of the m-PR™ app they found helpful or not helpful.
System usability scale
Participants rated their ease of use with the m-PR™ app via the System Usability Scale (SUS) which is a ten-item scale giving a global view of subjective assessment of usability of digital systems. 17 Responses were on a five-point Likert scale and scores ranged from 0 to 100, with 100 representing the best score 17 and a score of 68 or higher indicating an above average SUS score. 18
Participant interviews
Participants were invited to complete an individual, semi-structured interview via tele-conference, telephone or in-person, with a study researcher (SW) with extensive clinical and research experience in PR, to explore their experiences of using the m-PR™ app. A semi-structured interview guide (in appendix) was developed to determine acceptability of the m-PR™ app. Open-ended and probing questions allowed in-depth discussion. Interviews were audio recorded and transcribed verbatim using an external transcription service. Transcripts were deidentified by each participant being assigned a code. The theoretical framework of acceptability (TFA) (version 2) 19 was used as a multi-faceted construct to determine the acceptability of the m-PR™ app to people with COPD.
Data analysis
Participant characteristic data and outcome data were analysed using descriptive statistics of mean and standard deviation (SD) for continuous variables and numbers and percentages for categorical variables (IBM SPSS Statistics 27).
Satisfaction Survey: Each question in the participant satisfaction survey was evaluated separately and the absolute number and percentage of responses were determined for all participants across each scale. The anchor responses of the 5 point scale were grouped to provide a three level response. For example, when analysing the outcome of “enjoyment”: the “not at all enjoyable” was labelled as “not enjoyable”, the “neither” enjoyment level was labelled as “neutral”, and the “somewhat enjoyable”, “enjoyable” and “very enjoyable” were labelled as “enjoyable”. When analysing the outcome of ease of use and helpfulness, “very difficult / very unhelpful” and “somewhat difficult / somewhat unhelpful” were merged into “difficult / not helpful”, “neither” were labelled as “neutral”, “somewhat easy / somewhat helpful” and “very easy / very helpful” were labelled as “easy/helpful”. Scores were then determined for each question by allocating a “−1” to “not enjoyable/difficult/not helpful, “0” to “neutral” and 1 to “enjoyable/easy/helpful” with an average score and SD determined.
Participant Interviews: We conducted a systematic analysis of the interviews using a framework-based approach with five steps: 1. Familiarisation of the transcripts: A study researcher (MD) reviewed all transcripts identifying patterns and divergent views; 2. Identification of a thematic framework: From the initial coding, two study researchers (MD, ZM), both with extensive clinical and research experience working with patients with chronic respiratory diseases, identified key issues and concepts arising from the transcripts, applying these to the seven constructs of the TFA (v2); 3. Indexing: A study researcher (MD) applied single passages of text from all transcripts to the TFA (v2) which was reviewed and discussed by a different study researcher (ZM); 4. Charting: Two study researchers (MD, ZM) independently rearranged data according to the TFA, then finalised this step through an iterative process and presentation to a third researcher (SW); 5. Mapping and interpretation: Two study researchers (MD, ZM) explained the findings. 20
Results
Participant flow and characteristics
The flow of the study participants is presented in Figure 1. Fifteen out of 18 participants completed the study. Three participants did not complete the study with two participants withdrawing consent and one participant unable to be contacted after agreeing to participate. Participant characteristics are shown in Table 1. Participants had mild-to-severe COPD, a high proportion of co-morbidities and rated themselves as having good technology skills.

Participant flow.
Participant characteristics.
Legend: COPD: Chronic Obstructive Pulmonary Disease; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity.
Classification of severity of COPD is determined according to the GOLD Report. (21) GOLD 1 - mild: FEV1 ≥ 80% predicted. GOLD 2 - moderate: 50% ≤ FEV1 < 80% predicted. GOLD 3 - severe: 30% ≤ FEV1 < 50% predicted. GOLD 4 - very severe: FEV1 < 30% predicted.
Multiple responses possible.
Participant satisfaction survey
The level of enjoyment experienced by participants using the m-PR™ app is presented in Table 2. Of the fifteen participants, 10 (67%) participants scored “enjoyable”, 5 (33%) participants were neutral and there were no participants scoring “not enjoyable”. The ease of use and the helpfulness of the m-PR™ app is reported in Table 3. All participants who responded to the set of questions on “ease of use” found the education video component and communicating with the therapist component “somewhat easy” or “very easy”, with the latter component also found to be helpful to all participants. The exercise program component had the lowest mean score for ease of use (mean [SD] 0.46 [0.9]). Table 4 presents the perceived helpfulness of using different components of the m-PR™ app to improve COPD self-management. Most of the participants found the app “somewhat helpful” or “very helpful” for all the self-management factors, particularly “understanding of education topics”, “motivation to do the exercise program” and “motivation to take more steps each day”. Eleven of the 15 participants provided text-based comments in the survey on what they found “helpful” or “not helpful” about the m-PR™ app which has been included in Table 5. The major components that participants stated they found helpful were the education resources, the weekly contact with the physiotherapist, and the added incentive the m-PR™ app provided to help them complete tasks. The survey also identified that some participants found the m-PR™ app complex with the technical aspects being challenging.
The enjoyment level of the m-PR™ app.
The mean score was calculated from an allocation of: −1 (not enjoyable), 0 (neutral), or 1 (enjoyable).
Number of participants who found the different components of the m-PR™ app easy to use and helpful to use.
-The number of responders to each question was different and has been indicated below:
-Total numbers who responded to each “ease of use” component: Daily Monitoring (n = 15); Exercise Program (n = 13); Exercise Videos (n = 12); Education Videos (n = 11); Communicating with the therapist (n = 9).
-Total numbers who responded to each “helpful to use” component: Daily Monitoring (n = 14); Exercise Program (n = 13); Exercise Videos (n = 12); Education Videos (n = 12); Communicating with the therapist (n = 9).
-Scores for “ease of use” were calculated from an allocation of: −1 (difficult), 0 (neutral), or 1 (easy).
-Scores for “helpful to use” were calculated from an allocation of: −1 (not helpful), 0 (neutral), or 1 (helpful).
Number of participants who found the different components of the m-PR™ app helpful to use to improve self-management.
-The number of responders to each question varied and has been indicated below:
-Total numbers who responded to each component: Motivation to do the Exercise Program (n = 14); Motivation to take more steps each day (n = 12); Understanding of education topics (n = 14); Ability to monitor your symptoms (n = 14); Ability to manage your symptoms (n = 14).
-Scores were calculated from an allocation of: −1 (not helpful), 0 (neutral), or 1 (helpful).
Respondent comments on the satisfaction survey of the helpful and unhelpful parts of the m-PR™ app.
System usability scale
The SUS mean score of 71 (SD 16) demonstrates an above average score for the perceived usability of the m-PR™ app.
Participant interviews
Twelve participants consented to be interviewed following completion of the user testing. The interviews ranged in duration from 20 to 46 min (mean 33 min). Characteristics of participants who were interviewed are presented in Table 1 together with characteristics of the entire group. Participant quotes mapped to the TFA (v2) are presented in Table 6, with an indication after each quote on the participant's enjoyment level from the m-PR™ app survey data.
Consumer acceptability of the m-PR™ app.
TFA v2 = Theoretical Framework of Acceptability version 2 19
The m-PR™ app elicited divergent feelings among participants, who reported both positive and negative acceptability. Some participants liked the m-PR™ app features which tracked their progress, motivated them to exercise, monitored their symptoms and had educational components (e.g., educational videos). Participants also felt the m-PR™ app may help them to maintain their exercise program on completion of PR. However, some participants said they found the m-PR™ app contained too much information, they would miss the in-person interaction if they only used the m-PR™ app to complete their PR program, and it may be too difficult to use for those people unfamiliar with technology.
Some participants reported that using the m-PR™ app required minimal effort, whereas other participants perceived the m-PR™ app as requiring too much effort, with increased burden commonly due to too much information presented or technology problems. Participants expressed mixed views on sharing personal information and the need for data security.
Most participants reported that they understood the intervention and what was involved with using the m-PR™ app, although many said they were not compliant with all aspects of the m-PR™ app during user testing. Most participants perceived the m-PR™ app would be effective in delivering PR and felt confident that they would be able to participate in the program via the m-PR™ app, particularly those who were familiar with technology and willing to explore the m-PR™ app.
Discussion
There is limited research examining the user experience of mHealth platforms to deliver PR in people with COPD and this is the first study to examine the user experience of an Australian mobile pulmonary rehabilitation app (m-PR™). The findings of this study indicate that the majority of participants found the m-PR™ app enjoyable, easy to use and that the components helped to support their COPD self-management. The interview data indicated overall satisfaction with the m-PR™ app, however, there were differing opinions on the app's features, the effort required to use it and data security.
Overall, 67% of the participants found the m-PR™ app enjoyable whilst 33% were neutral. This level of enjoyment is similar to a previous study that reported high levels of satisfaction with a mHealth PR program in a small sample of participants. 12 The perceived enjoyment in utilising technology includes physiological, cognitive, and psychological components that are closely interconnected to each other. In the process of performing activities, enjoyment is likely to be experienced when a balance between skill and challenge is achieved. 21 Interestingly, when the participants who rated their enjoyment as “neutral” were questioned about why their enjoyment was “neutral”, they remained positive describing their experience as being “useful”, “OK” and “satisfactory”. This level of enjoyment with the m-PR™ app is not dissimilar to a study exploring another COPD self-management app in the Netherlands 22 which had a mean satisfaction level of 7.7 (SD 1.7) on a scale of 1 to 10 (with 1 representing not being satisfied at all, to 10 representing being very satisfied). 22
The majority of the participants considered all m-PR™ components easy to use, particularly for the “education videos”, “communicating with the therapist”, “daily monitoring” and “exercise videos” components. A similar result was found for the helpfulness of these components. These findings related well to the SUS score of 71 (SD 16) which also indicates an above average result for overall perceived usability of the m-PR™ app. The component with the lowest score in this section was the ease of use of the exercise program itself. Similar feelings about the exercise component of mHealth PR apps have been previously reported. 9 Given participants have to actively engage in this component by both completing the exercises and recording the dosage information, it is likely that this was the most complex task that was undertaken on the m-PR™ app and is the functionality that, in the future, people with COPD should be well supported about at the start of a program.
The self-management factors outlined in Table 4 had more variability in how people found them helpful, with the highest ranked factor being “understanding of education topics” and the lowest being “ability to manage your symptoms”. The latter result may be because the participants did not perceive that the management functions in the app (such as exercise training) changed symptoms such as breathlessness given the short-time frame in which they may have used the app (e.g., 4 weeks). Interestingly, in a randomised controlled trial of the MyCOPD online platform, 23 in which participants’ knowledge, skill and confidence for self-management was measured with the patient activation measurement (PAM), participants demonstrated a greater PAM level after 12 weeks of PR using MyCOPD when compared to usual care. This finding suggests that it may take time to master self-management skills and change health behaviours which is understandable given the complexity of tasks required to improve or maintain wellbeing in people living with COPD.
Similar to other mHealth app feedback,8,9,24 participants provided a mixture of positive and negative comments on the aspects they found helpful about the m-PR™ app (Table 5), and on the acceptability of components of the m-PR™ app (Table 6). Overall our findings build on previous work that has reported generally positive user experience and satisfaction in using mHealth platforms to deliver PR8,9,12 with our study indicating participants enjoyed the delivery of education through these platforms and were motivated by the technology to complete tasks and track progress. However, we have also determined that this innovative model of PR delivery may not be suitable or acceptable to all patients, particularly those who enjoy in-person interactions or who find technology too difficult to use. A future avenue for research is to determine who is best suited to participating in PR via an app together with measuring consumer adherence and engagement with the technology.
There are some limitations to this study. A convenience sample of COPD patients attending PR programs was used and recruitment was hindered due to COVID-19 restrictions resulting in a small sample size which may undermine the validity of the study findings. Participants in this study had mild-to-severe COPD, and therefore the findings of this study might not be transferable to people with severe-to-very severe COPD or those on long-term oxygen therapy, and future studies should explore how patients with a higher disease burden or those that use supplementary oxygen during exercise experience receiving PR via mHealth technology. All participants from this study self-rated their technology skills as at least being adequate, creating a potential sample bias of technology-engagers and therefore the study findings may not be applicable to COPD patients with limited technology skills. This bias might be due to the nature of the study: participants willing to engage with mHealth were highly likely to be familiar with mobile technology, i.e., technology-engagers themselves in life. Although this might be a limitation in terms of sample bias, in clinical practice it is likely that mHealth technology will be of more benefit to patients who are reasonably confident in their technology skills.
In conclusion, this user experience study has indicated that the majority of participants found the m-PR™ app enjoyable, easy to use and helpful in managing their COPD. Furthermore, the study provided useful information about the components of the m-PR™ app which people with COPD are willing to engage to improve self-management. These results suggest that mHealth programs are an acceptable way to deliver a digitally enabled PR program at home or in a centre, to people with COPD who have adequate technology skills.
Supplemental Material
sj-docx-1-dhj-10.1177_20552076241237381 - Supplemental material for User experience testing of the mobile pulmonary rehabilitation (m-PR™) app in people with chronic obstructive pulmonary disease
Supplemental material, sj-docx-1-dhj-10.1177_20552076241237381 for User experience testing of the mobile pulmonary rehabilitation (m-PR™) app in people with chronic obstructive pulmonary disease by Sally L Wootton, Marita T Dale, Ye Tian, Meredith King, Jennifer A Alison, Andrew S L Chan, Marlien Varnfield, Ian A Yang and Zoe J McKeough in DIGITAL HEALTH
Supplemental Material
sj-docx-2-dhj-10.1177_20552076241237381 - Supplemental material for User experience testing of the mobile pulmonary rehabilitation (m-PR™) app in people with chronic obstructive pulmonary disease
Supplemental material, sj-docx-2-dhj-10.1177_20552076241237381 for User experience testing of the mobile pulmonary rehabilitation (m-PR™) app in people with chronic obstructive pulmonary disease by Sally L Wootton, Marita T Dale, Ye Tian, Meredith King, Jennifer A Alison, Andrew S L Chan, Marlien Varnfield, Ian A Yang and Zoe J McKeough in DIGITAL HEALTH
Supplemental Material
sj-docx-3-dhj-10.1177_20552076241237381 - Supplemental material for User experience testing of the mobile pulmonary rehabilitation (m-PR™) app in people with chronic obstructive pulmonary disease
Supplemental material, sj-docx-3-dhj-10.1177_20552076241237381 for User experience testing of the mobile pulmonary rehabilitation (m-PR™) app in people with chronic obstructive pulmonary disease by Sally L Wootton, Marita T Dale, Ye Tian, Meredith King, Jennifer A Alison, Andrew S L Chan, Marlien Varnfield, Ian A Yang and Zoe J McKeough in DIGITAL HEALTH
Footnotes
Acknowledgements
The authors would like to acknowledge the contributions of the NSLHD Chronic Disease Community Rehabilitation Service at Royal North Shore Hospital, Hornsby Ku-ring-gai Hospital and Mona Vale Hospital. The authors would like to acknowledge CSIRO software engineers Derek Ireland and Simon Gibson for the creation of the m-PR™ app. The authors would like to acknowledge and thank the participants that took part in the study.
Authors’ contributions
The study was initially conceived by SW, ZM, JA, MD, MV, AC, and IY. All authors contributed to the study design. SW wrote the first draft of the manuscript. All authors contributed to writing of the manuscript and critically reviewed it. All authors approved the final version of the manuscript.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethics approval and consent to participate
This study has been approved by the NSLHD Human Research Ethics Committee (HREC reference: 2019/ETH14039). All participants gave their written informed consent to participate in the study. Data will be stored according to, and as required by, the ethics committee and will be available from the corresponding author on request.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The m-PR™ platform development was funded by a Northern Sydney Local Health District (NSLHD) innovation grant, a Metro North Hospital and Health Service seeding grant, and the Australian government Commonwealth Scientific and Industrial Research Organisation (CSIRO). A NSLHD Chronic and Complex Care, Primary and Community Health seeding grant supported the research.
Guarantor
Sally Wootton.
Supplemental material
Supplemental material for this article is available online.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
